Abstract
Purpose
Obstructive sleep apnea (OSA) and metabolic syndrome (MetS) are common chronic disorders associated with cardiovascular morbidity and mortality. The goal of our research is to identify the associations between OSA and MetS, including different components of MetS, in adults.
Methods
We used data from the 2007–2008 National Health and Nutrition Examination Survey, which included 5909 eligible subjects (2898 men, 3011 women), aged 20 and over, who had undergone a complete medical examination and had self-reported three OSA symptom items. The primary study outcome was possible obstructive sleep apnea (pOSA) and MetS components.
Results
Participants in the pOSA group had significantly more MetS components (p < 0.001). In the group aged ≥ 60 years, there was a stronger relationship between pOSA and MetS components. After additional adjustment, the odds ratios for pOSA among those with 2, 4, and 5 MetS components were 3.11, 3.19, and 4.89, respectively (p < 0.05).
Conclusions
In conclusion, our study indicates that the risk of pOSA is higher in association with increased MetS factors, particularly among the elderly. Leading a healthy lifestyle may help reduce OSA risk in elderly patients with MetS.
Similar content being viewed by others
References
Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52:686–717.
Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med: JCSM. 2009; 5: 263 – 76.
Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. Jama. 2012;307:2169–76.
Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52:343–6.
Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Critical Care Med. 2010;182 269 – 77.
Grassi G, Quarti-Trevano F, Seravalle G, Dell’Oro R. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr, Metab Cardiovasc Dis: NMCD. 2007; 17: 473–81.
Trombetta IC, Somers VK, Maki-Nunes C, Drager LF, Toschi-Dias E, Alves MJ, et al. Consequences of comorbid sleep apnea in the metabolic syndrome—implications for cardiovascular risk. Sleep. 2010;33:1193–9.
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society. 2008;5:136–43.
Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–9.
Nock NL, Li L, Larkin EK, Patel SR, Redline S. Empirical evidence for “syndrome Z”: a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep. 2009;32:615–22.
Diaz K, Faverio P, Hospenthal A, Restrepo MI, Amuan ME, Pugh MJ. Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients. Ann Thoracic Med. 2014;9:92–8.
Kinugawa K, Nguyen-Michel VH, Mariani J. [Obstructive sleep apnea syndrome: a cause of cognitive disorders in the elderly?] La Revue de Medecine Interne. 2014;35:664–9.
AlGhanim N, Comondore VR, Fleetham J, Marra CA, Ayas NT. The economic impact of obstructive sleep apnea. Lung. 2008;186:7–12.
Sands-Lincoln M, Grandner M, Whinnery J, Keenan BT, Jackson N, Gurubhagavatula I. The association between obstructive sleep apnea and hypertension by race/ethnicity in a nationally representative sample. J Clin Hypertens (Greenwich Conn). 2013;15:593–9.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.
Liaw FY, Kao TW, Hsueh JT, Chan YH, Chang YW, Chen WL. Exploring the Link between the Components of Metabolic Syndrome and the Risk of Depression. BioMed Res Int. 2015;586251.
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.
Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. Jama. 2004;291:2013–6.
Edwards BA, Wellman A, Sands SA, Owens RL, Eckert DJ, White DP, et al. Obstructive sleep apnea in older adults is a distinctly different physiological phenotype. Sleep. 2014;37:1227–36.
Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med: JCSM. 2007;3:467–72.
Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005;9:211–24.
Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Internal Med. 2003;254:32–44.
Kostoglou-Athanassiou I, Athanassiou P. Metabolic syndrome and sleep apnea. Hippokratia. 2008;12:81–6.
Bonsignore MR, Eckel J. ERS Meeting Report. Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev Off J Eur Respir Soc. 2009;18:113–24.
Peled N, Kassirer M, Shitrit D, Kogan Y, Shlomi D, Berliner AS, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med. 2007;101:1696–701.
Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339–48.
Huffman DM, Barzilai N. Role of visceral adipose tissue in aging. Biochimica et biophysica acta. 2009;1790:1117–23.
Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiological reviews. 2013;93:359–404.
Park MH, Kim DH, Lee EK, Kim ND, Im DS, Lee J, et al. Age-related inflammation and insulin resistance: a review of their intricate interdependency. Archives of Pharmacal Res. 2014;37:1507–14.
Lipina C, Vaanholt LM, Davidova A, Mitchell SE, Storey-Gordon E, Hambly C, et al. CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction. Aging cell. 2016;15:325–35.
Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5:2048004016633371.
Bakker JP, Weng J, Wang R, Redline S, Punjabi NM, Patel SR. Associations between obstructive sleep apnea, sleep duration, and abnormal fasting glucose. The multi-ethnic study of atherosclerosis. Am J Respir Crit Care Med. 2015;192:745–53.
Wu WT, Tsai SS, Shih TS, Lin MH, Chou TC, Ting H, et al. The association between obstructive sleep apnea and Metabolic markers and lipid profiles. PloS One. 2015;10:e0130279.
Liu KH, Chu WC, To KW, Ko FW, Ng SS, Ngai JC, et al. Mesenteric fat thickness is associated with metabolic syndrome independently of Apnoea-Hypopnoea Index in subjects with obstructive sleep apnoea. Respirology. 2016;21:533–40.
Chen GP, Qi JC, Wang BY, Lin X, Zhang XB, Zhao JM, et al. Applicability of visceral adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study. BMC Pulmonary Med. 2016;16:37.
Indications. and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med. 1994;150:1738–45.
Ward Flemons W, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Rev. 1997;1:19–32.
Yuan H, Schwab RJ, Kim C, He J, Shults J, Bradford R, et al. Relationship between body fat distribution and upper airway dynamic function during sleep in adolescents. Sleep. 2013;36:1199–207.
Cizza G, de Jonge L, Piaggi P, Mattingly M, Zhao X, Lucassen E, et al. Neck circumference is a predictor of metabolic syndrome and obstructive sleep apnea in short-sleeping obese men and women. Metabolic Syndrome Relat Disord. 2014;12:231–41.
Acknowledgements
There was no acknowledgement directly for this manuscript.
Funding
The authors received no funding for this work.
Author information
Authors and Affiliations
Contributions
Chen-Jung Wu contributed to the design of the study, was responsible for the management and retrieval of data, contributed to initial data analysis and interpretation, drafted the initial manuscript. Chen-Jung Wu, Tung-Wei Kao, Yaw-Wen Chang, and Wei-Liang Chen decided upon the data collection methods. Chen-Jung Wu and Wei-Liang Chen were also responsible for the data analysis decisions. Wei-Liang Chen conceptualized and designed the study, supervised all aspects of the study, critically reviewed and revised the manuscript, and approved the final manuscript as submitted. All authors meet the ICMJE criteria for authorship.
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they had no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Wu, CJ., Kao, TW., Chang, YW. et al. Examining the association between obstructive sleep apnea and cardiometabolic risk factors in the elderly. Sleep Biol. Rhythms 16, 231–237 (2018). https://doi.org/10.1007/s41105-018-0145-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41105-018-0145-y